Literature DB >> 20458764

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

Chao-Hung Hung1, Jing-Houng Wang, Tsung-Hui Hu, Chien-Hung Chen, Kuo-Chin Chang, Yi-Hao Yen, Yuan-Hung Kuo, Ming-Chao Tsai, Sheng-Nan Lu, Chuan-Mo Lee.   

Abstract

AIM: To elucidate the role of insulin resistance (IR) and serum adiponectin level in hepatocellular carcinoma (HCC) associated with chronic hepatitis C.
METHODS: Clinical and biochemical characteristics were collected from 165 consecutive patients with newly diagnosed HCC. Homeostasis model assessment of IR (HOMA-IR) and serum adiponectin level were investigated in 188 patients with different stages of hepatitis C virus (HCV) infection.
RESULTS: Among HCC patients, type 2 diabetics (DM) was more prevalent in HCV subjects (35.6%, n = 59) compared to hepatitis B virus (HBV; 12.7%, n = 63) or non-HBV, non-HCV cases (7.1%, n = 28). In patients with chronic hepatitis C, HCC subjects had higher blood sugar (P < 0.001), insulin level (P = 0.003) and HOMA-IR (P = 0.018) than those with chronic hepatitis and advanced fibrosis. Age, male sex and body mass index were significantly associated with serum adiponectin level, whereas HOMA-IR was not. Based on stepwise logistic regression analysis, age (OR: 1.124, P < 0.001), serum insulin level (OR: 1.585, P < 0.001), HOMA-IR (OR: 0.495, P = 0.001), DM (OR: 11.601, P = 0.002) and male sex (OR: 3.877, P = 0.016) were independently associated with HCC. This result was similar even if the diabetic subjects were excluded for analysis.
CONCLUSION: Insulin resistance measured by HOMA-IR, regardless of the presence of diabetes, is significantly associated with HCC development in patients with chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458764      PMCID: PMC2868220          DOI: 10.3748/wjg.v16.i18.2265

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  A prospective study of obesity and cancer risk (Sweden).

Authors:  A Wolk; G Gridley; M Svensson; O Nyrén; J K McLaughlin; J F Fraumeni; H O Adam
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

Review 2.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

3.  Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece.

Authors:  Eleni Petridou; Christos Mantzoros; Nick Dessypris; Panagiotis Koukoulomatis; Carol Addy; Zannis Voulgaris; George Chrousos; Dimitrios Trichopoulos
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

4.  Beta-cell deficiency, insulin resistance, or both?

Authors:  G F Cahill
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

Review 5.  Classification of chronic hepatitis: diagnosis, grading and staging.

Authors:  V J Desmet; M Gerber; J H Hoofnagle; M Manns; P J Scheuer
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

Review 6.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Obesity and cancer risk: a Danish record-linkage study.

Authors:  H Møller; A Mellemgaard; K Lindvig; J H Olsen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

Review 8.  Current pathogenetic and molecular concepts in viral liver carcinogenesis.

Authors:  P Schirmacher; C E Rogler; H P Dienes
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

9.  Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

Authors:  L B Seeff; Z Buskell-Bales; E C Wright; S J Durako; H J Alter; F L Iber; F B Hollinger; G Gitnick; R G Knodell; R P Perrillo
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

10.  Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.

Authors:  Chao-Hung Hung; Chuan-Mo Lee; Chien-Hung Chen; Tsung-Hui Hu; Shu-Rong Jiang; Jing-Houng Wang; Sheng-Nan Lu; Pei-Wei Wang
Journal:  Liver Int       Date:  2009-03-03       Impact factor: 5.828

View more
  36 in total

1.  Insulin resistance and chronic liver disease.

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Shuji Sumie; Michio Sata
Journal:  World J Hepatol       Date:  2011-05-27

2.  Insulin resistance in non-diabetic patients of chronic Hepatitis C.

Authors:  Zareen Kiran; Bader Faiyaz Zuberi; Daniah Anis; Rashid Qadeer; Khalid Hassan; Salahuddin Afsar
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

Review 3.  The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?

Authors:  Frank A Simmen; Rosalia C M Simmen
Journal:  Eur J Cancer Prev       Date:  2011-11       Impact factor: 2.497

Review 4.  Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.

Authors:  Letiția Adela Maria Streba; Cristin Constantin Vere; Ion Rogoveanu; Costin Teodor Streba
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 5.  Nutrition and Muscle in Cirrhosis.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-11-08

6.  The investigation of glucose metabolism and insulin secretion in subjects of chronic hepatitis B with cirrhosis.

Authors:  Chun-Hui Guo; Ting-Ting Sun; Xi-Ding Weng; Jian-Chun Zhang; Jian-Xin Chen; Guo-Jiong Deng
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma.

Authors:  K Hamdy; R Al Swaff; H A Hussein; M Gamal
Journal:  J Endocrinol Invest       Date:  2015-09-10       Impact factor: 4.256

8.  Selection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child-Pugh class B.

Authors:  Shintaro Kuroda; Hirotaka Tashiro; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

Review 9.  Insulin sensitizers for the treatment of non-alcoholic fatty liver disease.

Authors:  Zeynel Abidin Ozturk; Abdurrahman Kadayifci
Journal:  World J Hepatol       Date:  2014-04-27

10.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.